N-terminal truncated mutant enzyme of glucan sucrase and preparation method of N-terminal truncated mutant enzyme
A technology of glucan sucrase and mutant enzymes, which is applied in the field of N-terminal truncation mutant enzymes of dextran sucrase and its preparation, can solve the problems of substrate specific stability or catalytic efficiency limitation, and achieve stability Good results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0026] The present invention also provides a preparation method of the N-terminal truncation mutant enzyme of glucansucrase, comprising the following steps:
[0027] (1) After culturing the recombinant bacteria carrying the gene encoding the N-terminal truncation mutant enzyme of glucansucrase under the condition of 35-40°C for 10-14 hours, continue to culture until the OD600 of the bacterial solution reaches 0.5-0.7 Add IPTG to a final concentration of 0.8-1.2 mM, then culture at 24-26°C, 200-250 r / min for 3-5 h, collect the cells by centrifugation, resuspend the cells with sodium acetate buffer, and centrifuge to obtain the supernatant. The liquid is the crude enzyme liquid;
[0028] (2) Passing the obtained crude enzyme liquid through a nickel column for separation and purification to obtain the N-terminal truncation mutant enzyme of glucansucrase.
[0029] In the present invention, as described in step (1), the recombinant bacteria carrying the gene encoding the N-termina...
experiment example 1
[0037](1) Glucansucrase gene cloning: The dextransucrase gene dsrD of the present invention is derived from Leuconostoc mesenteroides, and primers P1 and P2 are designed with the full sequence of the bacteria (AY017384.1). Amplification. The nucleotide sequence of the P1 is shown in SEQ ID NO.10, the nucleotide sequence of the P2 is shown in SEQ ID NO.11, and PagI (PagI-qNcoI is a homozygous enzyme) and SacI are introduced into the primers The restriction site is convenient for ligation to the pET-30(a) vector. The amplified fragment is cloned to obtain the glucansucrase gene of the present invention. Wherein, the amino acid sequence of glucansucrase is shown in SEQ ID NO.1, and the nucleotide sequence of the gene encoding glucansucrase is shown in SEQ ID NO.2.
[0038] (2) Inducible expression of N-terminal truncation mutant enzyme and determination of its activity:
[0039] Five mutant enzymes were obtained by truncation of the glucansucrase gene obtained in step (1) at d...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com